Skip to Main Content

Paper Details

Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)?
Expert Opinion on Investigational Drugs
22
2020
-Klotho, FGF receptor, FGF19, FGF19 sub-family, FGF21, FGFR, Fibroblast, Fibroblast growth factor (FGF) 21, Fibroblast growth factor (FGF)-21, Klotho, NAFLD, fibrosis, glucose, hepatic fat infiltration, inflammation, nonalcoholic fatty liver disease
Author NameAffiliation
Timothy P RolphDepartment of Research and Development
  • 1 - 1

Datasets

Release 1.2